Home > Press > WallStreetSavant.com Announces Profile Coverage of Eugene Science, Inc.
Wall Street Savant, LLC ( http://www.wallstreetsavant.com ) today announced initiation of Profile Coverage on Eugene Science, Inc. on its website.
WallStreetSavant.com Announces Profile Coverage of Eugene Science, Inc.
Beaverton, OR | Posted on November 11th, 2007
Eugene Science, Inc. is a global Biotechnology company tackling ailments such as heart disease, obesity and diabetes through innovation in the Nutraceutical field. Its first commercial heart disease product, CZ™ is a patented, Nanoscience-based, water-soluble functional food ingredient containing natural plant sterols that help maintain healthy cholesterol levels by inhibiting its absorption.
Eugene Science is advancing the era of Pharmacogenomics, a pioneering field of Biotechnology, which is the predictive and personalized treatment of adult disease through individualized manipulation of foods, medicines, food and genes. These advances are made possible by the combination of Eugene Science's database on adult diseases combined with the Company's applied Bioinformatics technology.
To view Eugene Science's Profile please visit http://www.wallstreetsavant.com .
WallStreetSavant.com is a leading online financial portal where investors can discover an array of financial tools to help build their investment IQ. WallStreetSavant.com also provides comprehensive profiles on undiscovered and under-followed micro and small-cap companies as well as well researched opinions on stocks for active traders. The comprehensive profiles are featured on WallStreetSavant.com and members are kept abreast on all new developments through regular email updates.
To join their free email list please click here:
To feature your publicly traded company on WallStreetSavant.com, please contact them at 1-800-281-6469 or via email at
Forward-Looking Statements: With the exception of historical information, this news release and accompanying information may include forward-looking statements that involve a number of risks and uncertainties. Actual results could differ materially from those anticipated as a result of various risks. There are numerous factors that could contribute to such differences; therefore, such projected events and anticipated results are not warranties or guarantees that such events will occur or that the Company will achieve such results. For more information about this corporation and risks involved in the investment of their publicly traded shares, please see the Company's web site, and/or documents filed with the SEC. Disclosure: Wall Street Savant LLC expects to be compensated fifty thousand shares of EUSI by a non-controlling third party for profile coverage. Wall Street Savant LLC is not a registered investment advisers or broker/dealer. Wall Street Savant LLC makes no recommendation that the purchase of securities of companies profiled in its web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
For more information, please click here
Wall Street Savant, LLC
Copyright © WallStreetSavant.com
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014
Nanometrics Announces Upcoming Investor Events July 22nd, 2014
Harris & Harris Group Invests in UberSeq, Inc. July 16th, 2014
Harris & Harris Group Portfolio Company D-Wave Systems Closes a $28.4 Million Financing July 14th, 2014
Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014
NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014
SentiMag® Now Available in Australia and New Zealand July 21st, 2014
More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014
Silicene Labs Announces the Launch of Patent-Pending, 2D Materials Composite Index™ : The Initial 2D Materials Composite Index™ for Q2 2014 Is: 857.3; Founders Include World-Renowned Physicist and Seasoned Business and IP Professionals July 24th, 2014
Iranian Scientists Produce Transparent Nanocomposite Coatings with Longer Lifetime July 24th, 2014
Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014
A Crystal Wedding in the Nanocosmos July 23rd, 2014